Cough & Lung Sound Endpoints for Clinical Trials

The RESP® Platform

FDA 510(k) Cleared | CE Mark (Biosensor only)

Remote Respiratory Monitoring: RESP Biosensor

Technology Overview

The Strados Labs RESP® Platform enables life sciences teams to objectively measure respiratory symptoms and physiological signals in daily life, providing greater insight into treatment response and differentiation across clinical programs.

  • Patient-Friendly: Wireless, discreet form factor and privacy-preserving
  • Multi-Parameter: Comprehensive respiratory and physiological measures that matter to patients
  • Validated Reporting: Automated or manual (human) overread to meet endpoint requirements
RESP Biosensor for Clinical Trials

Clients & Partners

Measures

A robust combination of measures that reflect how patients feel and function

Cough Monitoring
          • Cough Frequency (24-hour)
          • Cough Bouts
          • Cough Sound Intensity
          • Wheeze, Rhonchi, Crackles
          • Breathing Patterns*
          • Respiratory Rate*
          • Heart Rate & Heart Rate Variability*
          • Orientation (e.g. Supine or Upright)*
          • Sleep/Wake*
          • Activity Levels*

*Measurement not FDA cleared but may be collected in clinical trials

Metrics-at-a-Glance

1.5M

Lung Sounds Captured

50M

Breaths Captured

5

Continents

34

Countries

36

Languages

245

Sites

Device Selection for Varying Applications

Digital Measures for Multiple Indications

Cough Wheeze Crackles Rhonchi Respiratory Rate* Heart Rate* Activity*
Chronic Cough
Pulmonary Fibrosis
Bronchiectasis
COPD
Asthma
Infectious Diseases
Lung Cancer
Congestive Heart Failure
  • Chronic Cough
  • IPF
  • Bronchitis
  • COPD
  • Asthma
  • RSV
  • Covid-19
  • Heart Failure

*Measurement not FDA cleared but may be collected in clinical trials

Why Include Cough & Lung Sounds as Endpoints?

  • Improve insight into how patients feel and function, strengthening evidence to regulatory agencies
  • Reduce reliance on questionnaires to demonstrate treatment effect on symptoms
  • Differentiate your asset in a competitive marketplace
  • Uncover signals that may point to new or expanded indications
  • Identify new pharmacologic insights into your treatment

 

Features & Specifications

    • Wireless and discreet
    • Patient-friendly form factor
    • Continuous
    • Data transfer to cloud
    • 24+ hour battery life
    • Water resistant
    • Patient-privacy preserving (HIPAA compliant)
    • Flexible reporting including automated or human analysis of cough and lung sounds
    • Verifications: FDA 510(k) Class II and CE Mark  (RESP Biosensor only) 

 

RESP Biosensor for Clinical Trials

Publications

Stepwise Validation Program

Cough Detection Performance of the CoughCheck Algorithm in Subjects with Subacute Cough

Poster Presentation, American Thoracic Society, 2025

Objective Cough Monitoring
Objective Cough Monitoring Detects More Patients with Cough Than Patient Self-Reporting

Poster Presentation, American Cough Conference, 2023

Results of Clinical performance testing in Chronic lung diseases
Results of Clinical Performance Testing in Chronic Lung Diseases

Poster Presentation, American Thoracic Society, 2022

Talk to our Team

Explore using the RESP® Biosensor in your next study